American society of nephrology-36th annual meeting and renal week 2003.
D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002118:Calcium / Q000502:physiology; D003928:Diabetic Nephropathies / Q000188:drug therapy; D018818:Fenoldopam / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy*; D018716:Molecular Mimicry; D009398:Nephrology; D011733:Pyridoxamine / Q000627:therapeutic use; D012313:RNA / Q000627:therapeutic use; D012076:Renal Agents / Q000627:therapeutic use*; D012958:Societies, Scientific; D014481:United States
D065092:Antidiuretic Hormone Receptor Antagonists; D000959:Antihypertensive Agents; D012076:Renal Agents; D012313:RNA; D011733:Pyridoxamine; D018818:Fenoldopam; D002118:Calcium